If you’ve seen headlines about CeraVe, cancer lawsuits, and a carcinogen hiding in your skincare, you’ve also probably felt that low-grade alarm that makes you want to throw your entire bathroom cabinet in the trash. Before you do that — and before you dismiss this as another viral panic — here’s what’s actually happening, what the science says, and what you should actually do.

The short answer: a real concern exists, six products were recalled, and the ingredient at the center of it is one of the most common in American acne care. But the full picture is more specific — and more nuanced — than the headlines suggest.

Where This Started: The Valisure Report, March 2024

In March 2024, Valisure — an independent drug quality testing laboratory based in New Haven, Connecticut — filed a citizen’s petition with the U.S. Food and Drug Administration. Their finding: benzoyl peroxide (BPO), the active ingredient in hundreds of over-the-counter acne products, can break down into benzene under certain conditions — including temperatures as low as room temperature or body heat.

Benzene is not a gray-area chemical. It is a known human carcinogen directly linked to leukemia and other blood cancers by the American Cancer Society, the EPA, and the World Health Organization. The WHO is explicit: no safe level of benzene exposure can be recommended.

Valisure’s testing detected benzene levels in BPO acne products ranging from 5 to over 800 times the FDA’s conditional limit of 2 parts per million (ppm). Their researchers published their initial findings in Environmental Health Perspectives in March 2024, followed by a peer-reviewed follow-up study in the Journal of Investigative Dermatology in October 2024. The breakdown of BPO into benzene, it should be noted, is not disputed — not by the companies named in lawsuits, and not by the FDA. The debate is specifically about how much degradation occurs under real-world conditions, and whether those levels pose meaningful cancer risk to users.

What the FDA Actually Found in 2025

Following Valisure’s petition, the FDA conducted its own independent testing of 95 acne products containing benzoyl peroxide. In March 2025, the agency released its results: more than 90% of tested products had undetectable or very low levels of benzene. Six products, however, exceeded safety thresholds and were voluntarily recalled.

The six recalled products were:

• La Roche-Posay Effaclar Duo Dual Action Acne Treatment
• Walgreens Acne Control Cleanser
• Proactiv Emergency Blemish Relief Cream (Benzoyl Peroxide 5%)
• Proactiv Skin Smoothing Exfoliator
• SLMD Benzoyl Peroxide Acne Lotion
• Walgreens Tinted Acne Treatment Cream

According to Yale School of Medicine, Dr. Christopher Bunick, MD, PhD — associate professor of dermatology and co-author on both studies — was unequivocal: “There shouldn’t be any carcinogens in any of our acne products. The recall is a victory for patient safety.”

An important clarification: CeraVe products were not among the six recalled by the FDA. CeraVe became part of this story because lawsuits were filed against its parent company, L’Oréal, citing Valisure’s testing data on CeraVe’s own BPO-containing acne cleansers. Those lawsuits allege benzene levels of 5 to 12 ppm in certain CeraVe acne products — above the FDA’s 2 ppm conditional limit. Those cases remain in active litigation. No verdict has been reached.

The Lawsuits Against L’Oréal and CeraVe

Multiple class action lawsuits have been filed against L’Oréal USA — CeraVe’s parent company — in the wake of Valisure’s report. The first was filed in March 2024 in the U.S. District Court for the Eastern District of Louisiana. Similar complaints have followed, with plaintiffs alleging exposure to unsafe benzene levels from CeraVe Acne Foam Cream Cleanser and CeraVe Acne Foaming Cream Wash.

The lawsuits also raise a secondary concern: that benzene continues to off-gas from BPO products even inside sealed packaging, creating an inhalation exposure risk for anyone in close proximity — not just the person applying it.

The litigation is ongoing. Attempts to consolidate the cases into a multi-district litigation (MDL) have so far been declined by the courts. No settlement has been announced.

What Benzene Actually Does — and Who Is Most at Risk

Benzene is a well-documented carcinogen. Long-term exposure has been linked to acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), non-Hodgkin’s lymphoma, multiple myeloma, and myelodysplastic syndrome, among other blood disorders. The EPA and American Cancer Society both classify it as a known human carcinogen.

Context matters here. As Dr. Bunick noted to Yale School of Medicine: “Benzene is in your acne products, it’s in your dry shampoos, it’s in your sunscreens, it’s in second-hand or direct cigarette smoke, it’s in exhaust from cars. It’s all the benzene exposure throughout all of society that adds cumulative risk. And the last place consumers need additional risk is in an acne product.”

Cumulative exposure is the key concept. Skin is a permeable barrier, and anything applied topically — especially to a disrupted barrier like acne-prone skin — has potential for systemic absorption. For certain populations, this matters more:

• Children and teenagers — who have thinner skin, faster cell turnover, and higher skin-to-body-weight surface area
• People with compromised immune systems — including those undergoing chemotherapy or managing chronic illness
• Elderly individuals — whose skin absorption patterns differ from younger adults
• Anyone with frequent, long-term BPO product use — where cumulative dose is highest

The Key Distinction the Headlines Keep Missing

Here is what the viral posts and the YouTube videos tend to collapse into one story but are actually two separate things:

1. The science question: Does benzoyl peroxide break down into benzene? Yes — this is established chemistry and not disputed by anyone.

2. The risk question: Do the benzene levels found in real-world product use pose a meaningful cancer risk to users? This is actively debated. The FDA’s own 2025 testing found that over 90% of BPO products had undetectable or negligibly low benzene. The six that didn’t were recalled. Valisure’s methodology — which tested products under elevated temperatures to simulate degradation over time — has been questioned by the FDA as not reflective of actual consumer exposure conditions.

That does not mean the concern is unfounded. It means the situation is: a known carcinogen, in products used daily by millions, at levels that vary widely by brand and formulation, with six products already recalled and litigation still pending. That is enough to warrant informed attention.

What to Actually Do Right Now

You don’t need to panic. You do need to check.

Step 1: Identify your products. Look at the active ingredients on any acne cleanser, spot treatment, toner, or face wash in your cabinet. If you see “benzoyl peroxide” listed, note the brand and product name.

Step 2: Cross-reference the FDA recall list. Go to FDA.gov’s drug alerts and statements page and search for the current list of recalled benzoyl peroxide products. If your product appears on it, stop using it and check the brand’s website for return or refund guidance.

Step 3: Store products correctly. Benzene formation accelerates with heat. Keep BPO products out of direct sunlight, out of hot cars, and away from high-temperature environments like steamy bathrooms. The chemistry degrades faster above room temperature.

Step 4: Talk to your dermatologist. If you’re using benzoyl peroxide as part of a prescribed or dermatologist-recommended routine — especially for moderate-to-severe acne — don’t discontinue without professional guidance. There are alternative active ingredients (azelaic acid, salicylic acid, adapalene, niacinamide) that your provider may recommend depending on your skin type and acne severity.

Step 5: Be more careful if you’re in a higher-risk group. If you’re applying BPO-based products to a child, an elderly parent, or someone who is immunocompromised, the calculus shifts. A conversation with their physician before continuing is worth 10 minutes.

The Bigger Picture

This story is part of a longer and increasingly uncomfortable pattern: trusted skincare and personal care products — sunscreens, dry shampoos, deodorants, and now acne treatments — turning out to contain or produce carcinogenic chemicals that were either unknown at the time of approval or not tested for under real-world conditions.

The FDA’s cosmetic and OTC drug regulatory framework was not built for this kind of proactive chemical degradation testing. Independent labs like Valisure are filling a gap that federal oversight hasn’t closed. Whether their methodology is perfectly calibrated to real-world risk is a legitimate scientific debate — but their role in triggering the 2025 recalls and peer-reviewed research is not.

The six recalls happened because their testing flagged the problem first. That matters.

What you take from this depends on your risk tolerance, your personal history, and who you’re buying these products for. But you now have the actual information — not the panic version, not the dismissal version. Use it.

Frequently Asked Questions

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. The information presented is based on publicly available research, FDA statements, and peer-reviewed studies. Do not discontinue any prescribed skincare treatment without first consulting your dermatologist or healthcare provider. For the most current FDA recall information, visit FDA.gov.

Legal Disclaimer: This article does not constitute legal advice. The litigation referenced is ongoing. No verdict or settlement has been reached in the cases described.

Want health and wellness reporting that actually respects your intelligence?
Subscribe to WMN Magazine — real information for women who don’t have time for noise.